title: Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 cell model: pharmaceutical and biopharmaceutical rationale for product standardization.
abstract: The purposes of this study were to determine content uniformity of phenolics in the St. John's wort (SJW) supplements and to demonstrate how variations in the product matrices affect their absorption and efflux. LC and LC-MS/MS methods were used to determine the phenolic contents of 12 different products purchased locally or from the Internet. Three representative extracts were further submitted to Caco-2 cell transport experiment, and transport of rutin, hyperoside, and isoquercitrin was evaluated. The results indicated that the 12 different products displayed 12 different HPLC fingerprints, but all products contained the following major compounds: rutin, hyperoside, isoquercitrin, quercitrin, quercetin, and amentoflavone. The content uniformity of these major compounds was poor across products, with the smallest difference in the amounts of amentoflavone (3.6-fold) and largest difference in that of isoquercitrin (28.8-fold). The Caco-2 experiments indicated transport of rutin in products was vectorial, with the permeabilities varied about 3.6-fold in both directions of transport. The vectorial permeabilities of hyperoside and isoquercitrin were similarly different. Use of efflux transporter inhibitor studies suggested that MRP2 was involved in isoquercitrin's efflux and the product matrix affected the extent of its efflux. In conclusion, different SJW supplements had highly variable contents of phenolics, and the variability in product matrix and phytochemical compositions affected the permeabilities of key phenolics across the Caco-2 monolayers, which may further affect their bioavailabilities. Therefore, standardization will be necessary to ensure safe and efficacious using of supplements such as SJW.
authors.affiliation: Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 1441 Moursund Street, Houston, Texas 77030, USA.
authors.forename: Song
authors.initials: S
authors.lastname: Gao
authors.forename: Wen
authors.initials: W
authors.lastname: Jiang
authors.forename: Taijun
authors.initials: T
authors.lastname: Yin
authors.forename: Ming
authors.initials: M
authors.lastname: Hu
mesh_terms: D001692:Biological Transport; D018938:Caco-2 Cells; D019587:Dietary Supplements / Q000592:standards*; D006801:Humans; D020902:Hypericum / Q000737:chemistry*; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D008954:Models, Biological; D010636:Phenols / Q000032:analysis* / Q000378:metabolism* / Q000494:pharmacology; D010936:Plant Extracts / Q000032:analysis* / Q000378:metabolism* / Q000494:pharmacology; D011786:Quality Control; D012015:Reference Standards
chemical_list: D010636:Phenols; D010936:Plant Extracts
references.citation: J Nutr. 2002 Apr;132(4):630-5
references.pmid: 11925453
references.citation: J Gen Intern Med. 2008 Jun;23(6):854-9
references.pmid: 18415652
references.citation: Pharmazie. 2008 Apr;63(4):296-302
references.pmid: 18468390
references.citation: Psychopharmacol Bull. 1993;29(4):427-30
references.pmid: 8084976
references.citation: J Agric Food Chem. 2004 Oct 6;52(20):6156-64
references.pmid: 15453681
references.citation: J Pharm Pharmacol. 2001 May;53(5):583-600
references.pmid: 11370698
references.citation: Planta Med. 2000 Feb;66(1):3-6
references.pmid: 10705724
references.citation: J Psychopharmacol. 2004 Jun;18(2):262-76
references.pmid: 15260917
references.citation: Life Sci. 2006 Nov 25;79(26):2455-62
references.pmid: 16989871
references.citation: Anal Chem. 2008 Mar 15;80(6):1978-87
references.pmid: 18260653
references.citation: Mol Nutr Food Res. 2005 Oct;49(10):957-62
references.pmid: 16189799
references.citation: Eur J Pain. 2009 Jan;13(1):109-10; author reply 111-2
references.pmid: 18789734
references.citation: Arch Oral Biol. 1983;28(7):583-90
references.pmid: 6579892
references.citation: Free Radic Res. 2008 Apr;42(4):372-7
references.pmid: 18404536
references.citation: Life Sci. 2002 May 17;70(26):3077-96
references.pmid: 12008092
references.citation: J Pharmacol Exp Ther. 2000 Sep;294(3):837-43
references.pmid: 10945831
references.citation: Eur J Pharmacol. 2007 Jul 2;566(1-3):67-74
references.pmid: 17481606
references.citation: Eur J Pharm Sci. 2006 Mar;27(4):354-62
references.pmid: 16364612
references.citation: J Affect Disord. 2008 Sep;110(1-2):16-26
references.pmid: 18456339
references.citation: Drug Metab Dispos. 2003 Nov;31(11):1288-91
references.pmid: 14570756
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):314-21
references.pmid: 12893842
references.citation: Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5
references.pmid: 1673839
references.citation: Arch Pharm Res. 1998 Feb;21(1):17-23
references.pmid: 9875509
references.citation: Free Radic Biol Med. 1990;9(2):99-104
references.pmid: 2172101
references.citation: Phytomedicine. 2009 Apr;16(4):277-83
references.pmid: 19299116
references.citation: Pediatr Rev. 2009 Jun;30(6):199-205; quiz 206
references.pmid: 19487428
references.citation: Pharm Res. 2006 Aug;23(8):1721-8
references.pmid: 16832612
references.citation: J Pharmacol Exp Ther. 2000 Sep;294(3):830-6
references.pmid: 10945830
references.citation: Am J Intellect Dev Disabil. 2009 May;114(3):147-60
references.pmid: 19374469
references.citation: Bioorg Med Chem. 2008 Apr 1;16(7):4009-18
references.pmid: 18249545
references.citation: Can J Clin Pharmacol. 2003 Fall;10(3):114-8
references.pmid: 14506510
references.citation: Drugs. 1996 Nov;52(5):625-38
references.pmid: 9118813